PRECOS appoints Dr Martin Page as scientific consultant

Brings oncology experience to Loughborough firm

Preclinical Oncology Services Limited (PRECOS), a UK-based pre-clinical research and development service provider focused on oncology, has appointed Martin Page as scientific consultant.

Page brings more than 28 years’ experience of oncology r&d leadership gained from the pharmaceutical and biotechnology sectors in the UK, Europe and the US to the Loughborough-based firm. His extensive therapeutic experience and industry knowledge will contribute to the company’s delivery of patient relevant models for oncology research.

Prior to this new role, Page was vice president, head of Global Oncology Research for Johnson & Johnson Pharmaceuticals, responsible for laboratories in Belgium and the US.

He has previously held senior positions as Oncology Therapeutic Area Head/Europe for Glaxo-Wellcome and senior director positions at biotechnology firms Oxford GlycoSciences and Oncogene Sciences.

You may also like

Research & Development

Crown Bioscience opens oncology biomarker R&D centre in California

New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development

Crown Bioscience and Charles River agree to expand access to ZDSD rat model

The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development

Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery

Services and capacity increase with new site opening
Research & Development

Crown Bioscience expands cardiovascular and metabolic disease research capability

The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development

CrownBio expands humanised models for targeted immunotherapy

The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development

Grant awarded to doctors researching innovative PDX models in immuno-oncology

Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Research & Development

CrownBio launches inflammatory disease models to advance research

The innovative pre-clinical models of inflammatory bowel disease and rheumatoid arthritis, mark the first of many that Crown Bioscience plans to release, as part of its commitment to serve autoimmune and inflammatory disease researchers
Subscribe now